Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-020-02315-9
Abstract: Purpose Intestinal dysbiosis has emerged as a biomarker of response to immune checkpoint inhibitors (ICIs). It can be caused by antibiotics, although it may also result from the use of other drugs that have been… read more here.
Keywords: intestinal dysbiosis; immune checkpoint; dysbiosis related; dysbiosis ... See more keywords
Upper‐airway dysbiosis related to frequent sweets consumption increases the risk of asthma in children with chronic rhinosinusitis
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.13417
Abstract: Innate immunity response to local dysbiosis seems to be one of the most important immunologic backgrounds of chronic rhinosinusitis (CRS) and concomitant asthma. We aimed to assess clinical determinants of upper‐airway dysbiosis and its effect… read more here.
Keywords: dysbiosis; dysbiosis related; airway dysbiosis; chronic rhinosinusitis ... See more keywords
Vaccine therapy for dysbiosis-related diseases
Sign Up to like & getrecommendations! Published in 2020 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v26.i21.2758
Abstract: Progress in genomic analysis has resulted in the proposal that the intestinal microbiota is a crucial environmental factor in the development of multifactorial diseases, such as obesity, diabetes, rheumatoid arthritis, and inflammatory bowel diseases represented… read more here.
Keywords: dysbiosis related; related diseases; therapy dysbiosis; vaccine therapy ... See more keywords